Dulera

Dulera® (mometasone/formoterol) inhaler is a prescription medication used for the long-term control of asthma. It combines two medicines: an inhaled corticosteroid (ICS) to reduce inflammation and a long-acting bronchodilator (LABA) to help keep airways open. It is designed to help prevent asthma symptoms over time, not to treat sudden breathing problems.

• Used for maintenance treatment of asthma in patients aged 5+
• Combines anti-inflammatory and airway-relaxing effects
• Helps reduce how often asthma symptoms occur
• Taken regularly as part of a daily treatment plan
• Not intended for sudden asthma attacks

Dulera® inhaler is used by breathing the medication into your lungs on a regular schedule, as prescribed by your healthcare provider. It is typically used every day, even when you feel well, to maintain asthma control.

• Inhale through the mouth using the inhaler device
• Use consistently as directed (not just when symptoms appear)
• Rinse your mouth after each use to reduce irritation risk
• Do not exceed the prescribed number of inhalations
• Avoid using other long-acting inhalers unless directed

Dulera® inhaler may cause side effects, and these can vary depending on how your body responds. Some are related to the airways, while others may require medical attention.

• Common effects include throat irritation, headache, or sinus-related symptoms
• You may notice a hoarse voice or mild discomfort in the mouth
• Oral fungal infection (thrush) can occur if the mouth is not rinsed
• Some people experience upper respiratory symptoms

Seek medical help right away if you notice:

• Worsening breathing or symptoms not improving
• Signs of an allergic reaction such as swelling, rash, or trouble breathing

If side effects feel severe or unusual, contact your healthcare provider or seek emergency care.

For more detail refer to the Important Safety / prescribing information.

Yes, but a licensed healthcare provider must review your information first. Telemedicine platforms can make this process more convenient, but they still require a proper medical evaluation before prescribing.

• Complete an online health questionnaire
• A provider reviews your symptoms and medical history
• Prescription is issued if appropriate
• Medication is dispensed through a licensed pharmacy

If your case needs further evaluation, your provider may suggest a different treatment.

Yes, Dulera® is the brand name, and mometasone/formoterol are the active ingredients in the inhaler. Both refer to the same type of combination medication used for long-term asthma control.

• Dulera® = brand name
• Mometasone/formoterol = active ingredients
• Both used for maintenance asthma treatment
• Availability may depend on your prescription and pharmacy

Your provider will decide what’s most appropriate for your treatment.

No, Dulera® is not a rescue inhaler. It is designed for regular use to help control asthma over time, not for immediate symptom relief.

• Not for sudden asthma attacks
• Does not replace a rescue inhaler
• Used for long-term asthma management

If you have sudden breathing symptoms, follow your provider’s instructions for quick-relief treatment.

Yes, Dulera® is typically used every day as prescribed. Consistent use helps maintain control of asthma symptoms and reduce flare-ups.

• Taken on a regular schedule
• Helps prevent symptoms over time
• Important to continue even when you feel well

Skipping doses may reduce its effectiveness. Always follow your provider’s instructions.

Dulera® is not intended for sudden symptom relief. If you experience a flare-up, you should use your rescue inhaler if one has been prescribed.

• Use a rescue inhaler for immediate symptoms
• Follow your asthma action plan
• Seek medical help if symptoms do not improve

If you’re unsure what to do, contact your healthcare provider.

If your symptoms are not improving, your treatment plan may need adjustment. Do not increase your dose without medical advice.

• Continue using as prescribed
• Track your symptoms
• Avoid changing your medication on your own

Contact your provider to review your treatment and next steps.

Dulera® is often used with other asthma medications, but combinations should always be guided by your provider.

• Inform your provider about all medications
• Avoid combining with similar long-acting inhalers unless directed
• Follow your prescribed treatment plan

Do not adjust or combine medications without medical advice.

Yes, rinsing your mouth after each use is recommended. This helps reduce the risk of irritation and oral infections.

• Rinse with water after each use
• Do not swallow the rinse water
• Helps lower risk of oral fungal infection

This is a simple step that can help reduce side effects.

There are no specific restrictions in the prescribing information, but individual responses can vary.

• Alcohol may increase certain side effects
• Effects differ between individuals
• Monitor how your body reacts

If you have concerns, discuss alcohol use with your provider.

Most people can continue normal activities after using Dulera®. However, some may experience side effects that affect concentration.

• Watch for dizziness or discomfort
• Avoid driving if you feel unwell
• Wait until you feel stable

If you notice unusual symptoms, allow time before driving.

If you miss a dose, take it as soon as you remember unless it’s close to your next scheduled dose.

• Do not double doses
• Return to your regular schedule
• Follow your provider’s instructions

Proper storage helps ensure your inhaler works correctly when needed.

• Keep the inhaler clean and dry
• Store according to label instructions
• Avoid extreme temperatures
• Keep out of reach of children

It’s best to request a refill before your inhaler runs out to avoid interruptions in treatment.

• Monitor your remaining doses
• Refill before reaching zero
• Follow your provider’s refill process

Dulera® (Mometasone Furoate/Formoterol Fumarate 100/5 mcg, 200/5 mcg) - combination inhaler (ICS + LABA) used for twice-daily maintenance treatment of asthma in patients 5 years and older; not for acute bronchospasm. / Source: NCBI

Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f399784-f257-4f31-b3dc-368bf2a1864d / Published: Not clearly shown on DailyMed.